Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical perspectives in lymphoma.

G A R Young1, H J Iland

  • 1Institute of Haematology, Royal Prince Alfred Hospital and Department of Medicine, University of Sydney, Sydney, New South Wales, Australia. graham.young@email.cs.nsw.gov.au

Internal Medicine Journal
|June 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late Relapses in Hodgkin's Disease: Are They a Distinct Entity?

Leukemia & lymphoma·2016
Same author

Rapid Screening of Mutant N-ras Alleles by Analysis of PCR-Induced Restriction Sites: Allele Specific Restriction Analysis (ASRA).

Leukemia & lymphoma·2016
Same author

Leukaemias into the 21st century. Part 2: the chronic leukaemias.

Internal medicine journal·2013
Same author

Leukaemias into the 21st century: part 1: the acute leukaemias.

Internal medicine journal·2012
Same author

Disseminated granulocytic sarcoma treated with allogeneic peripheral blood stem-cell transplantation.

Leukemia & lymphoma·2003
Same author

A spontaneous novel XK gene mutation in a patient with McLeod syndrome.

British journal of haematology·2001
Same journal

The paradox of peer review: protecting science or policing thought?

Internal medicine journal·2026
Same journal

Immune-related pancytopenia in pregnancy.

Internal medicine journal·2026
Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026
Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026
Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026
Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026
See all related articles

The classification of lymphomas, including Hodgkin's and non-Hodgkin's types, is evolving. Current approaches integrate pathogenesis, immunophenotypic, genotypic, and histopathological data for risk-adapted treatment strategies.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Lymphoma classification is dynamic, influenced by new research.
  • Understanding pathogenesis is key to accurate lymphoma diagnosis.
  • Immunophenotypic, genotypic, and histopathological features are crucial.

Purpose of the Study:

  • To outline the evolving classification of lymphomas.
  • To highlight the integration of diverse data in current lymphoma classification.
  • To emphasize risk-adapted treatment strategies in lymphoma management.

Main Methods:

  • Review of the latest World Health Organization (WHO) lymphoma classification.
  • Integration of data from pathogenesis, immunophenotypic, genotypic, clinical, and histopathological studies.

Related Experiment Videos

  • Analysis of risk-adapted treatment approaches combining chemotherapy, radiotherapy, and immunotherapy.

    • Main Results:

    • The World Health Organization classification represents an advancement in lymphoma categorization.
    • Current classification incorporates multiple data types for improved accuracy.
    • Improved patient outcomes are linked to risk-adapted, multi-modal therapies.

    Conclusions:

    • Lymphoma classification continues to evolve, integrating complex data.
    • Risk-adapted treatment strategies are essential for optimizing lymphoma patient outcomes.
    • Balancing treatment efficacy with reduced long-term toxicity is a primary goal in lymphoma care.